Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
“Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis”. Event: ASH 2019, Orlando.
2019
Research Type: Poster/Presentation
“Rivaroxaban Versus Warfarin and Renal Outcomes in Non-valvular Atrial Fibrillation Patients with Diabetes”. Event: ISTH 2019, Melbourne.
2019
Research Type: Poster/Presentation
“RIVAROXABAN VERSUS WARFARIN IN AFRICAN AMERICAN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation
“REAL-WORLD MANAGEMENT OF ORAL FACTOR XA INHIBITOR BLEEDING-RELATED HOSPITALIZATIONS WITH ANDEXANET ALFA OR 4 FACTOR PROTHROMBIN COMPLEX CONCENTRATE”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation
“OUTCOMES ASSOCIATED WITH BLEEDING-RELATED HOSPITALIZATIONS IN PATIENTS AT HIGH THROMBOTIC RISK FINDINGS FROM THE NATIONWIDE READMISSION DATABASE”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation
“Four-Year Incidence of Major Adverse Cardiovascular Events in Patients With Established Cerebrovascular Disease”. Event: ISC 2020, Los Angeles.
2020
Research Type: Poster/Presentation
“FOUR-YEAR INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ATRIAL FIBRILLATION PATIENTS WITH OR AT HIGH RISK FOR ATHEROSCLEROSIS”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation
“Effectiveness and safety of rivaroxaban versus warfarin in nonvalvular atrial fibrillation patients with coronary or peripheral artery disease”. Event: ESC Congress 2019, Paris.
2019
Research Type: Poster/Presentation
“Effectiveness and Safety of Rivaroxaban and Warfarin for Prevention of Major Adverse Cardiovascular or Limb Events in Nonvalvular Atrial Fibrillation Patients with Type 2 Diabetes”. Event: ISTH 2019, Melbourne.
2019
Research Type: Poster/Presentation
“Case clinic sessions: Tackling the challenge: High-risk NVAF patients”
2019
Research Type: Poster/Presentation
“Advantages of Once Daily Dosing on Medication Adherence and Persistence”.
2017
Research Type: Poster/Presentation
niversal Versus Platelet Reactivity Assay-Driven Use of P2Y12 Inhibitors in Acute Coronary Syndrome Patients: Cost-Effectiveness Analyses from Five European Perspectives
2013
Research Type: Poster/Presentation
ale to the EuroQol 5-Dimension Index Measure in North American Multiple Sclerosis Patients MMapping the 12-Item Multiple Sclerosis Walking Scale to the EuroQol 5-Dimension Index Measure in North American Multiple Sclerosis Patients
2012
Research Type: Poster/Presentation
Worsening of kidney function in patients with atrial fibrillation and chronic kidney disease: evidence from the real-world CALLIPER study.
2022
Research Type: Journal Article
What Proportion of Hospitalizations in Acute Medically Ill Patients Qualify for Extended Thromboprophylaxis with Oral Anticoagulation?
2019
Research Type: Poster/Presentation
What Characteristics of Schools/Colleges of Pharmacy Drive ‘US News and World Report’ Rankings?
2012
Research Type: Poster/Presentation
What Are the Effects of Nonsteroidal Anti-Inflammatory Drugs on Post-Cardiothoracic Surgery Outcomes?
2007
Research Type: Other Scholarly Work
Weekly Risk of Venous Thromboembolism Recurrence in Patients Receiving Oral Anticoagulants.
2014
Research Type: Journal Article